Rchr
J-GLOBAL ID:201801001658594731   Update date: Aug. 27, 2025

TAKAKU Tomoiku

タカク トモイク | TAKAKU Tomoiku
Affiliation and department:
Job title: Professor
Research field  (2): Molecular biology ,  Hematology and oncology
Research keywords  (7): Cell Organera ,  Ghost Cytometry ,  Mitochondria ,  Chronic myeloid Leukemia ,  Hematopoitic stem cell niche ,  Hematopoietic stem cell ,  Bone marrow imaging
Research theme for competitive and other funds  (4):
  • 2021 - 2024 TKI治療抵抗性の慢性骨髄性白血病細胞に対する新規治療戦略の開発
  • 2011 - 2015 Analysis of hematopoietic regulation system by circadian rhythm
  • 2011 - 2013 Development of the new treatment strategy of ATRA-resistant APL using PP2A-FOXO3A activation pathway
  • 2005 - 2007 Applications of molecular nanotechnology for human disease using DNA-encode based gene expression analysis
Papers (83):
  • Erina Hosoya, Jun Ando, Shintaro Kinoshita, Yoshiki Furukawa, Yuko Toyoshima, Yoko Azusawa, Toru Mitsumori, Eriko Sato, Hina Takano, Yutaka Tsukune, et al. Eleven cases of laryngeal edema after tisagenlecleucel infusion: a 3-year single center retrospective study of CD19-directed chimeric antigen receptor T-cell therapy for relapsed and refractory B-cell lymphomas. Haematologica. 2024
  • Chikashi Yoshida. Asciminib: the next-generation bullet for first-line treatment of chronic myeloid leukemia. Med. 2024
  • Yoshiki Furukawa, Jun Ando, Midori Ishii, Shintaro Kinoshita, Ayaka Goto, Kota Tachibana, Yoko Azusawa, Takao Kato, Norihide Izumi, Erina Hosoya, et al. l-asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein-Barr virus infection. British journal of haematology. 2024
  • Noriyoshi Iriyama, Eisaku Iwanaga, Yuta Kimura, Naoki Watanabe, Maho Ishikawa, Hitomi Nakayama, Eriko Sato, Takayuki Tabayashi, Toru Mitsumori, Tomoiku Takaku, et al. Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group. International journal of hematology. 2024. 120. 1. 60-70
  • Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Michiko Ichii, Takeshi Okatani, Hiromi Omura, Kei Nakajima, Makoto Sasaki, Jun Ando, Tomoiku Takaku, et al. Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan. Hematology. 2024. 29. 1. 2340149-2340149
more...
MISC (95):
more...
Patents (1):
Books (1):
  • Recent findings and advances in treatment of chronic myeloid leukemia
    2024
Lectures and oral presentations  (18):
  • ラージコホートでのリアルワールドデータを用いたCML患者におけるarterial occlusive events(AOE)の解析
    (第86回日本血液学会学術集会 2024)
  • 新規CML-CP患者での超高齢者集団におけるTKI治療解析
    (第86回日本血液学会学術集会 2024)
  • 腎機能障害を持つ慢性骨髄背白血病患者の予後
    (第86回日本血液学会学術集会 2024)
  • CML-CSGデータベースを用いたCML患者におけるダサチニブによる糖尿病の改善効果
    (第86回日本血液学会学術集会 2024)
  • 人工知能を用いたラベルフリーのCML細胞検出への挑戦
    (第86回日本血液学会学術集会 2024)
more...
Professional career (1):
  • Medicval Doctor, Doctor of Philisophy (Tokyo Medical University)
Work history (2):
  • 2024/04 - 現在 Saitama Medical University Division of Hematology Professor
  • 2007/10 - 2010/09 National Insitutes of Health National Heart Lung and Blood institute Post doctal fellow
Committee career (6):
  • 2024/09 - 現在 日本血液学会 J-SKI研究委員会
  • 2024/09 - 現在 日本血液学会 IJH編集委員
  • 2023/03 - 現在 Japan Cytometry Society board director
  • 2019/10 - 現在 Japanese Society of Hematology Executive Committee of TFR
  • 2018/10 - 現在 Japanese Society of Hematology Program committee member
Show all
Awards (4):
  • 2012 - National Institutes of Health Orloff Award
  • 2008/06 - Tokyo Medical University Hippocrates
  • 2008 - Tokyo Medical University Hippocrates Award
  • 2006 - Tokyo Medical University Sasa Memorial Award
Association Membership(s) (5):
Japanese Onco-Cadiology Society ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  American Society of Hematology ,  JAPAN CYTOMETRY SOCIETY ,  THE JAPANESE SOCIETY OF HEMATOLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page